Duke Researcher Shapes GLP-1 Drug Future

A Duke University researcher plays a pivotal role in advancing GLP-1 drugs, the popular medications revolutionizing weight loss and diabetes treatment. These drugs, like Ozempic and Wegovy, mimic hormones to curb appetite and regulate blood sugar. The expert contributes to studies enhancing their safety, efficacy, and long-term use amid skyrocketing demand. As side effects and supply issues persist, this work promises refinements for broader patient access. Read more about this...